Several studies indicated that the expression of HOTAIR frequently changes during malignant transformation and may be a key molecule in breast carcinogenesis and cancer progression, with the potential to serve as a novel biomarker and therapeutic target. The gene discussed is HOTAIR; the disease is medical procedure.